Skip to main content

Table 2 Univariate analyses of survival in vulvar cancer patients

From: The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer

Variables Categories Overall survival p
HR 95 % CI
Nodal status Negative for metastases 1 1.59–5.22 0.0005
Positive for metastases 2.88
Adjuvant RTX Yes 1 2.22–7.30 0.000005
No 4.02
Histologic grade Low (G1) 1 1.65–7.15 0.001
High (G2 + G3) 3.43
p16 status Positive 1 1.11–3.81 0.0216
Negative 2.06
FIGO stage I, II, III, IV 1.62 1.23–2.12 0.000592
Depth of invasion Continuous 1.05 0.96–1.15 0.283261
Age <60 1 1.12–5.59 0.025436
>60 2.5